Home
>
National Drug Code (NDC)
>
REBIF REBIDOSE
REBIF REBIDOSE - 44087-3322-1 - (INTERFERON BETA-1A)
Drug Information of REBIF REBIDOSE
| Product NDC: | 44087-3322 |
| Proprietary Name: | REBIF REBIDOSE |
| Non Proprietary Name: | INTERFERON BETA-1A |
| Active Ingredient(s): | 22 ug/.5mL & nbsp; INTERFERON BETA-1A |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of REBIF REBIDOSE
| Product NDC: | 44087-3322 |
| Labeler Name: | EMD Serono, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103780 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20121221 |
Package Information of REBIF REBIDOSE
| Package NDC: | 44087-3322-1 |
| Package Description: | 12 PACKAGE in 1 CARTON (44087-3322-1) > .5 mL in 1 PACKAGE (44087-3322-9) |
NDC Information of REBIF REBIDOSE
| NDC Code | 44087-3322-1 |
| Proprietary Name | REBIF REBIDOSE |
| Package Description | 12 PACKAGE in 1 CARTON (44087-3322-1) > .5 mL in 1 PACKAGE (44087-3322-9) |
| Product NDC | 44087-3322 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | INTERFERON BETA-1A |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20121221 |
| Marketing Category Name | BLA |
| Labeler Name | EMD Serono, Inc. |
| Substance Name | INTERFERON BETA-1A |
| Strength Number | 22 |
| Strength Unit | ug/.5mL |
| Pharmaceutical Classes | Interferon-beta [Chemical/Ingredient],Recombinant Human Interferon beta [EPC],Recombinant Proteins [Chemical/Ingredient] |
